Distribution and characterization of GFP+ donor hematogenous cells in Twitcher mice after bone marrow transplantation

YP Wu, E McMahon, MR Kraine, R Tisch… - The American Journal of …, 2000 - Elsevier
YP Wu, E McMahon, MR Kraine, R Tisch, A Meyers, J Frelinger, GK Matsushima, K Suzuki
The American Journal of Pathology, 2000Elsevier
The twitcher mouse is a murine model of globoid cell leukodystropy, a genetic demyelinating
disease caused by a mutation of the galactosylceramidase gene. Demyelination of the
central nervous system commences around 20 postnatal days. Using GFP-transgenic mice
as donors, the distribution of hematogenous cells after bone marrow transplantation was
investigated in the twitcher mice. Bone marrow transplantation was carried out at 8 postnatal
days. In twitcher chimeric mice examined before 30 postnatal days, numerous GFP+ cells …
The twitcher mouse is a murine model of globoid cell leukodystropy, a genetic demyelinating disease caused by a mutation of the galactosylceramidase gene. Demyelination of the central nervous system commences around 20 postnatal days. Using GFP-transgenic mice as donors, the distribution of hematogenous cells after bone marrow transplantation was investigated in the twitcher mice. Bone marrow transplantation was carried out at 8 postnatal days. In twitcher chimeric mice examined before 30 postnatal days, numerous GFP+ cells were detected in spleen and peripheral nerve but only a few were detected in the liver, lung, and spinal white matter. In contrast, at 35 to 40 postnatal days when demyelination is evident, many GFP+ cells with ameboid form were detected in the white matter of the spinal cord, brainstem, and cerebrum. Approximately half of these GFP+ cells were co-labeled with Mac-1. In twitcher chimeric mice examined after 100 postnatal days, the majority of GFP/Mac-1 double-positive cells displayed the morphological features of ramified microglia with fine delicate processes and was distributed diffusely in both gray and white matter. These results suggest that a significant number of donor hematogenous cells are able to infiltrate into the brain parenchyma, repositioning themselves into areas previously occupied by microglia, and to ameliorate lethality.
Elsevier